INS and type 1 diabetes mellitus: <h4>Aims/introduction</h4>To evaluate the real-world efficacy of sensor-augmented pump (SAP) for long-term glycemic control and glycemic variability indices.<h4>Materials and methods</h4>This was a single-center, retrospective, observational study that included individuals with type 1 diabetes who switched from multiple daily injections to SAP or continuous subcutaneous insulin infusion (CSII).